Palmitoylation plays an important role in regulating PD-L1 stability, and disrupting PD-L1 palmitoylation by site-specific point mutations or inhibiting the expression of its palmitoyltransferase ZDHHC9 can sensitize cancer cells to T-cell killing and in turn inhibits tumor growth[21]. Here, CD274 is linked to neoplasm.